Published in J Clin Microbiol on December 01, 1990
Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev (2004) 7.95
Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev (2006) 7.85
The medically important aerobic actinomycetes: epidemiology and microbiology. Clin Microbiol Rev (1994) 7.26
Nocardia species: host-parasite relationships. Clin Microbiol Rev (1994) 4.96
Clinical and laboratory features of Nocardia nova. J Clin Microbiol (1991) 3.32
Rapid identification of clinically significant species and taxa of aerobic actinomycetes, including Actinomadura, Gordona, Nocardia, Rhodococcus, Streptomyces, and Tsukamurella isolates, by DNA amplification and restriction endonuclease analysis. J Clin Microbiol (1997) 3.12
Identification of nocardia species by restriction endonuclease analysis of an amplified portion of the 16S rRNA gene. J Clin Microbiol (2000) 3.05
Phylogeny of the genus Nocardia based on reassessed 16S rRNA gene sequences reveals underspeciation and division of strains classified as Nocardia asteroides into three established species and two unnamed taxons. J Clin Microbiol (2003) 2.88
Evaluation of partial 16S ribosomal DNA sequencing for identification of nocardia species by using the MicroSeq 500 system with an expanded database. J Clin Microbiol (2004) 2.82
New Nocardia taxon among isolates of Nocardia brasiliensis associated with invasive disease. J Clin Microbiol (1995) 2.52
DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex. J Clin Microbiol (1995) 2.16
Nocardia veterana as a pathogen in North American patients. J Clin Microbiol (2003) 2.03
Analysis of secA1 gene sequences for identification of Nocardia species. J Clin Microbiol (2006) 1.94
Clinical application of PCR-restriction enzyme pattern analysis for rapid identification of aerobic actinomycete isolates. J Clin Microbiol (1998) 1.93
Identification of medically relevant Nocardia species with an abbreviated battery of tests. J Clin Microbiol (2002) 1.77
Sequence-based identification of aerobic actinomycetes. J Clin Microbiol (2004) 1.70
In vitro activities of linezolid against multiple Nocardia species. Antimicrob Agents Chemother (2001) 1.62
Nocardia kruczakiae sp. nov., a pathogen in immunocompromised patients and a member of the "N. nova complex". J Clin Microbiol (2004) 1.54
Yeast killer systems. Clin Microbiol Rev (1997) 1.47
Partial characterization of Nocardia farcinica beta-lactamases. Antimicrob Agents Chemother (1993) 1.31
Nocardia wallacei sp. nov. and Nocardia blacklockiae sp. nov., human pathogens and members of the "Nocardia transvalensis Complex". J Clin Microbiol (2008) 1.26
Novel method for rapid identification of Nocardia species by detection of preformed enzymes. J Clin Microbiol (1996) 1.22
Opacification of Middlebrook agar as an aid in identification of Nocardia farcinica. J Clin Microbiol (1993) 1.21
Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species. J Clin Microbiol (2012) 1.12
Fatty acid characterization of rapidly growing pathogenic aerobic actinomycetes as a means of identification. J Clin Microbiol (1997) 1.10
Disseminated Nocardia farcinica: literature review and fatal outcome in an immunocompetent patient. Surg Infect (Larchmt) (2012) 1.10
Ribotyping: a tool for taxonomy and identification of the Nocardia asteroides complex species. J Clin Microbiol (1996) 1.10
Rapid identification of Nocardia farcinica clinical isolates by a PCR assay targeting a 314-base-pair species-specific DNA fragment. J Clin Microbiol (2004) 1.09
Molecular study of nosocomial nocardiosis outbreak involving heart transplant recipients. J Clin Microbiol (1996) 1.05
Isolation of Nocardia paucivorans from the cerebrospinal fluid of a patient with relapse of cerebral nocardiosis. J Clin Microbiol (2002) 1.03
Characterization of human clinical isolates of Dietzia species previously misidentified as Rhodococcus equi. Eur J Clin Microbiol Infect Dis (2011) 0.96
Fatal pulmonary Nocardia farcinica infection. J Clin Microbiol (2002) 0.96
Opacification of Middlebrook agar as an aid in distinguishing Nocardia farcinica within the Nocardia asteroides complex. J Clin Microbiol (1994) 0.96
Antimicrobial susceptibility among clinical Nocardia species identified by multilocus sequence analysis. Antimicrob Agents Chemother (2014) 0.96
Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria. Antimicrob Agents Chemother (1996) 0.94
In vitro activity of fluoroquinolones against clinical isolates of Nocardia identified by partial 16S rRNA sequencing. Eur J Clin Microbiol Infect Dis (2007) 0.94
Identification of pathogenic Nocardia species by reverse line blot hybridization targeting the 16S rRNA and 16S-23S rRNA gene spacer regions. J Clin Microbiol (2009) 0.93
Severe keratitis due to Nocardia farcinica. J Clin Microbiol (1997) 0.89
Nocardia nova as the causative agent in spondylodiscitis and psoas abscess. J Clin Microbiol (2007) 0.89
Molecular and biochemical analysis of AST-1, a class A beta-lactamase from Nocardia asteroides sensu stricto. Antimicrob Agents Chemother (2001) 0.89
Human Nocardia Infections: A Review of Pulmonary Nocardiosis. Cureus (2015) 0.87
Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis (2011) 0.86
Left thigh phlegmon caused by Nocardia farcinica identified by 16S rRNA sequencing in a patient with leprosy: a case report. BMC Infect Dis (2013) 0.84
Brain abscess caused by Nocardia asiatica. Surg Neurol Int (2016) 0.84
Evaluation of the integrated database network system (IDNS) SmartGene software for analysis of 16S rRNA gene sequences for identification of Nocardia species. J Clin Microbiol (2010) 0.83
A fatal case of Nocardia otitidiscaviarum pulmonary infection and brain abscess: taxonomic characterization by molecular techniques. Ann Clin Microbiol Antimicrob (2009) 0.83
Nocardiosis in a patient with primary anti-phospholipid syndrome. Rheumatol Int (2006) 0.81
Nocardia infections among immunomodulated inflammatory bowel disease patients: A review. World J Gastroenterol (2015) 0.80
Pulmonary and psoas muscle nocardiosis in a patient with lupus nephritis: a case report and review of the literature. Rheumatol Int (2009) 0.79
Superior vena cava syndrome associated with Nocardia farcinica infection. Thorax (1997) 0.79
Implantable defibrillator pocket infection and bacteremia caused by Nocardia nova complex isolate. J Clin Microbiol (2003) 0.79
Use of yeast killer system to identify species of the Nocardia asteroides complex. J Clin Microbiol (1995) 0.78
The role of oral co-trimoxazole in treating Nocardia farcinica keratitis-a case report. J Ophthalmic Inflamm Infect (2016) 0.77
Clinical Pathway in the Treatment of Nocardial Brain Abscesses following Systemic Infections. Case Rep Neurol Med (2014) 0.76
Successful medical management of a Nocardia farcinica multiloculated pontine abscess. BMJ Case Rep (2013) 0.76
In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest. J Clin Microbiol (2016) 0.75
Antimicrobial susceptibilities of Nocardia spp. Antimicrob Agents Chemother (1993) 0.75
Thigh abscess due to Nocardia farcinica. J Natl Med Assoc (2006) 0.75
The role of oral co-trimoxazole in treating Nocardia farcinica keratitis: a case report. J Ophthalmic Inflamm Infect (2016) 0.75
Separate Nocardia infections in a patient with chronic granulomatous disease. J Clin Microbiol (2001) 0.75
Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob Agents Chemother (1988) 5.56
A comparative study of some strains received as nocardiae. J Bacteriol (1957) 3.86
Susceptibility testing of Nocardia species for the clinical laboratory. Diagn Microbiol Infect Dis (1988) 3.09
Identification of nocardiae and streptomycetes of medical importance. J Clin Microbiol (1980) 2.87
The type species of the genus Nocardia. J Gen Microbiol (1962) 2.34
Numerical analysis of the taxonomy of Nocardiae and Rhodococci. Microbiol Immunol (1982) 1.82
Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid. J Infect Dis (1987) 1.70
Differences among Nocardia spp. in susceptibility to aminoglycosides and beta-lactam antibiotics and their potential use in taxonomy. Antimicrob Agents Chemother (1983) 1.67
Numerical taxonomy of the genus Nocardia. J Gen Microbiol (1969) 1.66
Numerical taxonomy of Nocardia. Can J Microbiol (1973) 1.62
Antibiotic sensitivity of some nocardioform bacteria and its value as a criterion for taxonomy. J Gen Microbiol (1974) 1.58
Numerical classification of some named strains of Nocardia asteroides and related isolates from soil. J Gen Microbiol (1980) 1.51
Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides. Antimicrob Agents Chemother (1983) 1.51
In-vitro susceptibility of Nocardia asteroides to 21 beta-lactam antibiotics, in combination with three beta-lactamase inhibitors, and its relationship to the beta-lactamase content. J Antimicrob Chemother (1985) 1.46
In-vitro susceptibility testing of Nocardia spp. and its taxonomic implication. J Antimicrob Chemother (1988) 1.42
Delineation of Nocardia farcinica by delayed type skin reactions on guinea pigs. J Gen Microbiol (1968) 1.38
Seven cases of human nocardiosis caused by Nocardia farcinica. Sabouraudia (1975) 1.03
A case of lung infection caused by an unusual strain of Nocardia farcinica. Microbiol Immunol (1988) 1.01
Nocardiae that recently caused lung infection in Japan--Nocardia asteroides and Nocardia farcinica. Microbiol Immunol (1982) 1.00
Differentiation between genera Rhodococcus and Nocardia by susceptibility testing to kanamycin and some other antituberculosis agents. Microbiol Immunol (1988) 0.97
Nocardia asteroides. A taxonomic study with clinical correlations. Am Rev Respir Dis (1973) 0.93
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature (1991) 16.77
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet (2008) 6.50
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature (1998) 5.98
Etiology of human breast cancer: a review. J Natl Cancer Inst (1973) 5.88
Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob Agents Chemother (1988) 5.56
The reliability of the Alcohol Timeline Followback when administered by telephone and by computer. Drug Alcohol Depend (1996) 5.35
Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol (1999) 5.08
Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J Cell Biol (1998) 4.52
PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J Clin Microbiol (1995) 4.27
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med (1997) 4.18
Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol (1998) 3.84
Antibodies of the IgA type in intestinal plasma cells of germfree mice after oral or parenteral immunization with ferritin. J Exp Med (1969) 3.79
DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. J Clin Microbiol (1993) 3.65
Translation of poliovirus RNA in vitro: changes in cleavage pattern and initiation sites by ribosomal salt wash. Virology (1979) 3.61
Identification of a human population infected with simian foamy viruses. Nat Med (1998) 3.47
Separation of viable schizont-infected red cells of Plasmodium falciparum from human blood. Ann Trop Med Parasitol (1978) 3.40
Clinical and laboratory features of Nocardia nova. J Clin Microbiol (1991) 3.32
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol (2008) 3.31
Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother (1994) 3.28
Electrocardiographic criteria for ventricular tachycardia in wide complex left bundle branch block morphology tachycardias. Am J Cardiol (1988) 3.18
Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1999) 3.16
Rapid identification of clinically significant species and taxa of aerobic actinomycetes, including Actinomadura, Gordona, Nocardia, Rhodococcus, Streptomyces, and Tsukamurella isolates, by DNA amplification and restriction endonuclease analysis. J Clin Microbiol (1997) 3.12
Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation (2000) 3.12
Susceptibility testing of Nocardia species for the clinical laboratory. Diagn Microbiol Infect Dis (1988) 3.09
Adaptive licensing: taking the next step in the evolution of drug approval. Clin Pharmacol Ther (2012) 3.08
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother (1996) 2.92
Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J Clin Microbiol (1986) 2.87
The patient-centred clinical method. 2. Definition and application. Fam Pract (1986) 2.83
Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis (1992) 2.78
Childhood maltreatment increases risk for personality disorders during early adulthood. Arch Gen Psychiatry (1999) 2.73
Human disease due to Mycobacterium smegmatis. J Infect Dis (1988) 2.68
Proposal of a new genus, Gordona, for slightly acid-fast organisms occurring in sputa of patients with pulmonary disease and in soil. J Gen Microbiol (1971) 2.66
A co-operative numerical analysis of rapidly growing mycobacteria. J Gen Microbiol (1972) 2.63
Identification of mycobacteria. Tubercle (1967) 2.60
Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2002) 2.60
Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires. J Clin Oncol (1999) 2.59
Cigarette smoking and urinary estrogens. N Engl J Med (1982) 2.55
Adansonian classification of mycobacteria. J Gen Microbiol (1966) 2.53
New Nocardia taxon among isolates of Nocardia brasiliensis associated with invasive disease. J Clin Microbiol (1995) 2.52
Immunohistochemical observations on lymphoid tissues from conventional and germ-free mice. Lab Invest (1970) 2.45
Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism. J Clin Microbiol (1993) 2.40
Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy. Int J Syst Evol Microbiol (2001) 2.38
Identification and partial characterization of Mycobacterium avium and Mycobacterium intracellulare by using DNA probes. J Clin Microbiol (1989) 2.37
Notch gene expression during pancreatic organogenesis. Mech Dev (2000) 2.36
MEK kinase activity is not necessary for Raf-1 function. EMBO J (2001) 2.36
A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. J Infect Dis (1998) 2.34
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. Am J Respir Crit Care Med (1996) 2.30
Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic tool. J Clin Microbiol (1993) 2.25
A review of the methods of identification and differentiation of mycobacteria. Rev Infect Dis (1982) 2.24
A prospective cytogenetic study of 36 cases of DiGeorge syndrome. Am J Hum Genet (1992) 2.23
Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax (2004) 2.22
Physicians certified in family medicine. What are they doing 8 to 10 years later? Can Fam Physician (2001) 2.21
Molecular determinants of voltage-dependent gating and binding of pore-blocking drugs in transmembrane segment IIIS6 of the Na(+) channel alpha subunit. J Biol Chem (2001) 2.20
Infection after total knee arthroplasty. J Bone Joint Surg Br (2004) 2.17
Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum. J Infect Dis (1991) 2.17
DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex. J Clin Microbiol (1995) 2.16
Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis. Am Rev Respir Dis (1985) 2.16
Nanoliter scale PCR with TaqMan detection. Nucleic Acids Res (1997) 2.11
Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry (1996) 2.10
Parent-offspring coadaptation and the dual genetic control of maternal care. Science (2001) 2.10
Large restriction fragment patterns of genomic Mycobacterium fortuitum DNA as strain-specific markers and their use in epidemiologic investigation of four nosocomial outbreaks. J Clin Microbiol (1992) 2.07
Highly aggressive behaviour of occult papillary thyroid carcinoma. J Laryngol Otol (1995) 2.04
The effect of single prenatal and natal complications upon the development of children of mature birthweight. Pediatrics (1969) 2.04
Percutaneous endoscopic gastrostomy: evaluation of insertion by an endoscopy nurse practitioner. Eur J Gastroenterol Hepatol (1996) 2.03
Vitamin D3 and brain development. Neuroscience (2003) 2.01
Prevalence of Bartonella henselae antibodies in pet cats throughout regions of North America. J Infect Dis (1995) 2.00
Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am J Respir Crit Care Med (1994) 1.97
Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother (1990) 1.96
Involving South Asian patients in clinical trials. Health Technol Assess (2004) 1.93
Clinical application of PCR-restriction enzyme pattern analysis for rapid identification of aerobic actinomycete isolates. J Clin Microbiol (1998) 1.93
The patient-centred clinical method. 3. Changes in residents' performance over two months of training. Fam Pract (1986) 1.93
Atlas vertebra realignment and achievement of arterial pressure goal in hypertensive patients: a pilot study. J Hum Hypertens (2007) 1.91
Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med (1993) 1.90
Isoelectric focusing patterns of beta-lactamases in the rapidly growing mycobacteria. Tuber Lung Dis (1992) 1.89